Hainan Poly Pharm Balance Sheet Health
Financial Health criteria checks 2/6
Hainan Poly Pharm has a total shareholder equity of CN¥2.8B and total debt of CN¥2.7B, which brings its debt-to-equity ratio to 96.7%. Its total assets and total liabilities are CN¥6.3B and CN¥3.4B respectively.
Key information
96.7%
Debt to equity ratio
CN¥2.72b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥331.37m |
| Equity | CN¥2.81b |
| Total liabilities | CN¥3.45b |
| Total assets | CN¥6.25b |
Recent financial health updates
No updates
Recent updates
What Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 46% Share Price Gain Is Not Telling You
Oct 08
Hainan Poly Pharm. Co., Ltd (SZSE:300630) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
Aug 16It's Down 27% But Hainan Poly Pharm. Co., Ltd (SZSE:300630) Could Be Riskier Than It Looks
Apr 21A Piece Of The Puzzle Missing From Hainan Poly Pharm. Co., Ltd's (SZSE:300630) 27% Share Price Climb
Mar 06Financial Position Analysis
Short Term Liabilities: 300630's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 300630's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥2.1B).
Debt to Equity History and Analysis
Debt Level: 300630's net debt to equity ratio (84.9%) is considered high.
Reducing Debt: 300630's debt to equity ratio has increased from 12.7% to 96.7% over the past 5 years.
Debt Coverage: 300630's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 300630's interest payments on its debt are well covered by EBIT.